Prof G Markets: Scott’s NJOY Stake, the JetBlue/Spirit Merger, and WeightWatchers Buys Ozempic Maker

Pharma Solutions

WeightWatchers' strategic move into the pharmaceutical market highlights the growing role of drugs like Ozempic in tackling obesity. Scott Galloway notes that WeightWatchers' acquisition positions them well in a $50 billion market by 2030, with Ozempic prescriptions rising 80% year-on-year 1. He emphasizes the need for pharmaceuticals in weight loss, drawing from personal experience with creatine's benefits 2.

Shaming people doesn't work. This is a really deep, complex problem that involves culture, economics, access to the right diet.

--- Scott Galloway

Scott advocates for realistic solutions to address obesity, a significant issue in America.

   

Economic Impact

The economic implications of obesity are profound, affecting healthcare costs and societal structures. Scott discusses how the industrial food complex profits from unhealthy diets, leading to a dependency on the medical industry 1. He criticizes the politicization of obesity, stressing the need for open dialogue about its impact on public health.

I think obesity is a big issue.

--- Scott Galloway

Scott calls for a concerted effort to provide resources to combat this growing epidemic.